• Anna's DayBreak News
  • Posts
  • Trump’s ‘Golden Fleet’, Wegovy Pill Approved and Reducing Memory Deficits

Trump’s ‘Golden Fleet’, Wegovy Pill Approved and Reducing Memory Deficits

In partnership with

Anna's Daybreak News

Just facts, you think for yourself

Tuesday, 5:18 AM

December 23, 2025

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Trump’s ‘Golden Fleet’

President Trump announced the "Trump-class," a new fleet of 20-25 large battleships to modernize the U.S. Navy. The first ship, USS Defiant, will weigh 30,000-40,000 tons, with construction starting soon and a 2.5-year build time.

These ships will replace the DDG(X) destroyer program and feature hypersonic missiles, electromagnetic rail guns, and high-powered lasers. Fully built in the U.S., they aim to create thousands of jobs.

The battleships prioritize carrier protection and long-range strikes, costing about $5 billion each. The plan also includes a new FF(X) frigate class, replacing the canceled Constellation program.

The Navy currently has 287 ships. Critics question the strategic value against China.

Do you believe investing $5 billion per ship in large battleships is a wise use of U.S. defense resources?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Wegovy Pill Approved

Novo Nordisk’s Wegovy pill, containing 25 mg semaglutide, received FDA approval for weight loss, the first oral drug of its kind in the US.

Clinical trials showed an average 16.6% weight loss over 64 weeks, with one-third of participants losing 20% or more, versus 2.7% for placebo. Launch is set for January 2026, targeting adults with obesity or overweight plus at least one related condition.

The pill offers a daily oral alternative to injections. Novo Nordisk’s shares rose nearly 10% after approval. The new drug may boost sales amid competition from Eli Lilly and compounded versions. The global weight-loss drug market could reach $150 billion annually by 2030.

Sources: Bloomberg, Reuters, AP News, BBC.

Have you personally used or considered using prescription medication for weight loss?

Click to see live results and comment!

Login or Subscribe to participate in polls.

In 1924, Otto Warburg discovered a dirty secret about cancer cells.

They don't burn energy like healthy cells. They ferment sugar. They are metabolic parasites.

He won a Nobel Prize for it. Then, modern medicine largely forgot it.

Instead of starving the disease, we built a system that waits for it to grow.

The cost of this amnesia is staggering. Standard screenings now miss 71% of cancers until symptoms appear.

By then, the survival rate crashes from 43% to 3%.

We are fixing the broken narrative.

Our latest Deep Dive, The Anti-Cancer Protocol, uncovers the metabolic and technological tools that turn the tables.

It covers the Warburg Effect, the new blood tests that see the invisible, and the off-label drugs that block the fuel supply.

Stop playing defense.

Gold and Silver Soar

Gold rose over 68% in 2025, reaching nearly $4,500 an ounce, with 50 record-breaking days. Silver surged 138% to $69.44 an ounce, and platinum hit a 17-year high. Drivers include geopolitical tensions, trade conflicts, and expectations of further U.S. Federal Reserve rate cuts after three cuts in 2025.

Inflation remains near 3%, and the labor market is slowing. Central banks increased gold reserves by 1,136 tonnes in 2022. The U.S. dollar weakened 11% against other currencies, boosting precious metals demand.

Oil prices rose modestly after a U.S. naval blockade on Venezuelan tankers but remain below 2025’s start. Analysts warn of overbought conditions and potential volatility in metals prices.

Sources: Bloomberg, BBC, Fxstreet, ABC

Is the recent surge in gold and silver prices primarily a reflection of real economic instability or speculative market behavior?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Most people think a standard "A/B Trust" is the answer. They copy the old playbook. They "set and forget" their estate plans thinking they are protected.

And they lose.

Here is the brutal truth: mimicking old strategies guarantees failure in 2026. If you are relying on a trust drafted before the new $15M exemption, you aren't saving taxes. You are accidentally disinheriting your spouse.

I’ve spent the last week deconstructing The "Formula Clause" Trap, and what I found changes the entire playbook for estates between $5M and $30M.

We aren't talking about legal theory. We stripped away the noise to look at the math: how a simple "maximum tax-free" clause now forces 100% of your assets into a locked box, leaving your partner with zero control. It’s a silent error that passes every legal check but fails the reality test.

This isn't for the skimmers. It’s for the proactive few who want to stop a liquidity crisis before it starts.

The "safe" choice is to assume your lawyer fixed it. The profitable choice is to check the math.

Deadly Blasts in Moscow

Lieutenant General Fanil Sarvarov, head of the Russian Armed Forces’ Operational Training Directorate, was killed by a car bomb in Moscow.

Investigators suspect Ukrainian intelligence involvement but have not confirmed any leads. This is the third assassination of a senior Russian military official by bombing in just over a year, following the deaths of Lieutenant Generals Igor Kirillov and Yaroslav Moskalik.

Sarvarov had combat experience in Ossetia, Chechnya, and Syria. These attacks highlight ongoing covert warfare amid the nearly four-year Russia-Ukraine conflict, with Ukraine targeting Russian officials inside Russia, while Moscow denies accusations of sabotage in Europe.

Sources: AP News, Reuters, BBC, Thetimes.

Should these assassinations be seen primarily as acts of covert warfare or as criminal terrorism?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Reducing Seizures and Memory Deficits

Researchers found that aged glial cells accumulate in temporal lobe epilepsy (TLE) brains, increasing seizures and memory loss.

In mice with TLE, removing about 50% of these senescent cells using genetic methods or a drug combo (dasatinib and quercetin) cut seizures, improved maze performance, and prevented epilepsy in one-third of cases. Human epileptic tissue showed five times more aged glial cells than normal.

Dasatinib is FDA-approved for leukemia; quercetin is an antioxidant, both showing safety in trials. This approach could offer new treatment for drug-resistant epilepsy, potentially reducing surgery needs. Researchers are also investigating connections between aged brain cells and diseases like Alzheimer’s.

Sources: SciTechDaily.

How acceptable is it to repurpose existing drugs (like leukemia treatments) for neurological diseases?

Click to see live results and comment!

Login or Subscribe to participate in polls.

High-Fat Diets Prime Liver Cells for Cancer Development

MIT researchers found that a high-fat diet causes mature liver cells (hepatocytes) to revert to an immature, stem-like state, promoting survival under fat stress but increasing cancer risk.

In mice, this cellular regression activates survival and division genes while suppressing normal liver functions. Nearly all mice on a high-fat diet developed liver cancer. Key fetal transcription factors like SOX4 drive this change, accelerating tumor development when mutations occur.

Human liver tissues show similar gene patterns, with higher survival gene levels linked to shorter post-diagnosis survival. The cancer development process may span about 20 years, influenced by diet, alcohol, and infections. These transcription factors offer targets for cancer prevention.

Sources: SciTechDaily

Which best describes your current diet?

Click to see live results and comment!

Login or Subscribe to participate in polls.

Malice is a sharpshooter looking for a soft target, and if you go pointing out exactly where your armor is thin, you can’t blame the world for taking the shot.

Information is free. Intelligence is scarce.

You are one of 550,000 readers receiving this briefing. That is a crowd.

To join the 1,100 investors who receive our redacted contract briefings and wealth defense protocols, you need to step behind the velvet rope.

Join the Inner Circle.

Baked with love,

Anna Eisenberg ❤️

What did you think of today's edition?

Click to see live results and comment!

Login or Subscribe to participate in polls.